Hematology (United Kingdom)
Published by Taylor & Francis (Journal Finder)
ISSN : 1024-5332 eISSN : 1607-8454
Abbreviation : Hematol. (united Kingd.
Aims & Scope
Hematology is an international open access journal publishing original and review articles in the field of general hematology, including oncology, pathology, biology, clinical research and epidemiology.
Of the fixed sections, annotations are accepted on any general or scientific field: technical annotations covering current laboratory practice in general hematology, blood transfusion and clinical trials, and current clinical practice reviews the consensus driven areas of care and management.
Hematology aims to bridge the interests and practices of both those carrying out laboratory work and those whose main inclination is towards patient care.
The journal provides a forum where the clinical aspects of any published material will be emphasised.
The editors welcome papers from all related areas of research including: -General hematology- Oncology- Pathology- Biology- Clinical research- Epidemiology- Thalassemias and leukemias
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 1.6 |
| 2024 | 2.00 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.515 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q3 |
h-index
| Year | Value |
|---|---|
| 2024 | 52 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 11300 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 850 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 4,165.00 AUD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells
Citation: 68
Authors: Haiying, Qian, Shusen, Meifang, Anhua, Lili, Zhiqiang, Xin
-
Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come
Citation: 42
Authors: Salah, Mamdouh, Tarek, Manal, Hassan, Doaa
-
Clonal expanded TCR Vβ T cells in patients with APL
Citation: 21
Authors: Yangqiu, Shaohua, Lijian, Yubing, Xiuli, Meijuan, Suxia
-
Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging
Citation: 16
Authors: Pustika Amalia, Felix, Damayanti, Siti Ayu, Vasili, Dudley J.
-
Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis
Citation: 13
Authors: Fabrice, Surinder S.
-
Multiple littoral cell angioma of the spleen in a case of myelodysplastic syndrome
Citation: 13
Authors: Cengiz, YeÅŸim, Abdullah, A.Turgut
-
Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases
Citation: 9
Authors: Jiejing, Jie, Hong, Chunji, Lei, Wenbin, Haitao
-
Mixed-type autoimmune haemolytic anaemia: Unusual cases and a case associated with splenic T cell angioimmunoblastic non-Hodgkins lymphoma
Citation: 7
Authors: Nay, Divya, Victoria L., Malcolm, Anil